Cargando…

Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots

BACKGROUND: Venous thromboembolism (VTE) is associated with significant morbidity and mortality. OBJECTIVES: We investigated the impact of direct and AT‐dependent FXa or thrombin inhibitors on thrombus formation. METHODS: Whole blood thromboelastometry and thrombin generation were assessed after tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salta, Stella, Papageorgiou, Loula, Larsen, Annette K., Van Dreden, Patrick, Soulier, Claire, Cokkinos, Dennis V., Elalamy, Ismail, Gerotziafas, Grigoris T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles: Thrombosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178701/ https://www.ncbi.nlm.nih.gov/pubmed/30349889 http://dx.doi.org/10.1002/rth2.12120

Ejemplares similares

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19
por: Gerotziafas, Grigoris, et al.
Publicado: (2020)

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study
por: Fotiou, Despina, et al.
Publicado: (2018)

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study
por: Van Dreden, Patrick, et al.
Publicado: (2020)

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms
por: Papageorgiou, Loula, et al.
Publicado: (2022)

Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study
por: Van Dreden, Patrick, et al.
Publicado: (2022)

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process
por: Papageorgiou, Loula, et al.
Publicado: (2019)

Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Unraveling a borderline antithrombin deficiency case with quantitative mass spectrometry
por: Kruijt, Mirjam, et al.
Publicado: (2021)

Clot‐targeted magnetic hyperthermia permeabilizes blood clots to make them more susceptible to thrombolysis
por: Cabrera, David, et al.
Publicado: (2022)

Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation
por: Lu, Genmin, et al.
Publicado: (2020)

Effect of anticoagulants on fibrin clot structure: A comparison between vitamin K antagonists and factor Xa inhibitors
por: Gauer, Julia S., et al.
Publicado: (2020)

Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo
por: Perzborn, E, et al.
Publicado: (2014)

The intestinal microbiome potentially affects thrombin generation in human subjects
por: Mohammed, Yassene, et al.
Publicado: (2019)

Citrullinated fibrinogen forms densely packed clots with decreased permeability
por: Varjú, Imre, et al.
Publicado: (2022)

Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII
por: Demers, Melanie, et al.
Publicado: (2022)

Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay
por: Gerotziafas, Grigoris T, et al.
Publicado: (2005)

Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Defects of splicing in antithrombin deficiency
por: de la Morena‐Barrio, María E., et al.
Publicado: (2017)

Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics
por: Reda, Sara, et al.
Publicado: (2021)

Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study
por: Wiegers, Hanke M. G., et al.
Publicado: (2021)

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study
por: Gerotziafas, Grigoris T., et al.
Publicado: (2017)

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
por: Gerotziafas, Grigoris T, et al.
Publicado: (2014)

Cleavage of talin by calpain promotes platelet-mediated fibrin clot contraction
por: Fong, Karen P., et al.
Publicado: (2021)

Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants
por: Papageorgiou, Loula, et al.
Publicado: (2023)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
por: Mahé, Isabelle, et al.
Publicado: (2019)

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
por: Mahé, Isabelle, et al.
Publicado: (2019)

Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort
por: Blondon, Marc, et al.
Publicado: (2022)

Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation
por: Parunov, Leonid A., et al.
Publicado: (2023)

Crucial roles of red blood cells and platelets in whole blood thrombin generation
por: Sun, Siyu, et al.
Publicado: (2023)

Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in mice
por: Grover, Steven P., et al.
Publicado: (2022)

Structure of shear-induced platelet aggregated clot formed in an in vitro arterial thrombosis model
por: Kim, Dongjune A., et al.
Publicado: (2022)

COVID-19 Is Associated with Endothelial Dysfunction and Enhanced Plasma Thrombin Generation Despite Pharmacological Thromboprophylaxis
por: Kelliher, Sarah, et al.
Publicado: (2021)

Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19
por: Wygrecka, Malgorzata, et al.
Publicado: (2022)

Differential sialic acid content in adult and neonatal fibrinogen mediates differences in clot polymerization dynamics
por: Nellenbach, Kimberly, et al.
Publicado: (2021)

Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation
por: Negreva, Mariya, et al.
Publicado: (2016)

Fibrin protofibril packing and clot stability are enhanced by extended knob-hole interactions and catch-slip bonds
por: Asquith, Nathan L., et al.
Publicado: (2022)

Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study
por: Hamulyák, Eva N., et al.
Publicado: (2020)

A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation
por: Wan, Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rgsujn1n5948errl2344jmhv9g